Bristol Myers Squibb (BMY) Debt Ratio (2016 - 2026)

Bristol Myers Squibb has reported Debt Ratio over the past 18 years, most recently at 0.51 for Q1 2026.

Quarterly Debt Ratio fell 4.41% to 0.51 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.51 through Mar 2026, down 4.41% year-over-year, with the annual reading at 0.5 for FY2025, 6.55% down from the prior year.
Debt Ratio was 0.51 for Q1 2026 at Bristol Myers Squibb, up from 0.5 in the prior quarter.
Over five years, Debt Ratio peaked at 0.56 in Q1 2024 and troughed at 0.4 in Q3 2022.
The 5-year median for Debt Ratio is 0.5 (2025), against an average of 0.47.
Year-over-year, Debt Ratio decreased 8.07% in 2023 and then soared 40.12% in 2024.
A 5-year view of Debt Ratio shows it stood at 0.41 in 2022, then increased by 2.92% to 0.42 in 2023, then grew by 28.28% to 0.54 in 2024, then dropped by 6.55% to 0.5 in 2025, then rose by 2.62% to 0.51 in 2026.
Per Business Quant, the three most recent readings for BMY's Debt Ratio are 0.51 (Q1 2026), 0.5 (Q4 2025), and 0.51 (Q3 2025).

Peer Comparison